Announced Tue, 7 Jul · 15:04 IST
Board meeting on July 23, 2026 to consider Q1 FY27 results
Results View source PDF
NOVARTIND · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
+0.1%1-day move
₹1452.00
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————+0.1+0.9+3.3+16.2+12.3+10.0+9.0———
Up moveDown movePending
AI summary
Novartis India has informed BSE that its Board of Directors will meet on Thursday, July 23, 2026, to consider and approve the Unaudited Financial Results for the quarter ended June 30, 2026. This is a routine regulatory intimation under SEBI LODR Regulations, 2015, with no financial figures disclosed at this stage.
Likely market impact
Routine advance notice. Watch for the actual Q1 results announcement on or after July 23 for earnings performance.